Gadofosveset Injectable Solution Suppliers & Bulk Manufacturers
Available Forms: Injectable Solution
Available Strengths: 0.03 mmol/kg
Reference Brands: Ablivar(US & EU)
Category:
Contrast Agent
Gadofosveset is a gadolinium-based contrast agent that binds to serum albumin, prolonging blood vessel retention and enhancing vascular imaging. It provides high-resolution angiography, improved visualization of blood vessels, and supports accurate diagnosis of cardiovascular and vascular diseases. Benefits include detailed imaging, longer study duration, and early disease detection.
Gadofosveset Injectable solution is available in Injectable Solution
and strengths such as 0.03 mmol/kg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Gadofosveset Injectable solution is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Gadofosveset Injectable solution can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Gadofosveset, marketed as Ablivar, is approved in the US by the FDA and in the EU via EMA for high-resolution vascular MRI imaging. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing requirements. For dossier preparation, regulatory pathways, and market access guidance, visit PharmaTradz. Proper adherence supports swift approval, safe administration, and global availability, enabling precise cardiovascular and vascular imaging worldwide, supporting early diagnosis and treatment planning to improve patient outcomes.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing